| 000 | 01322 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250511184822.0 | ||
| 264 | 0 | _c19930114 | |
| 008 | 199301s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1038/clpt.1992.195 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAndrawis, N S | |
| 245 | 0 | 0 |
_aEndothelin-I-mediated vasoconstriction: specific blockade by verapamil. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _cDec 1992 |
||
| 300 |
_a583-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aEndothelins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aForearm _xblood supply |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNitroprusside _xpharmacology |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aVerapamil _xpharmacology |
| 700 | 1 | _aGilligan, J | |
| 700 | 1 | _aAbernethy, D R | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 52 _gno. 6 _gp. 583-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/clpt.1992.195 _zAvailable from publisher's website |
| 999 |
_c1465256 _d1465256 |
||